Skip to content
akaturk Academic measurement
Sign in Register

Academician

İRFAN KOCA

PROFESÖR

YOZGAT BOZOK ÜNİVERSİTESİ FEN-EDEBİYAT FAKÜLTESİ KİMYA BÖLÜMÜ

  • Ana Dal Fen Bilimleri ve Matematik Temel Alanı
  • Yan Dal Kimya

A quick look at recorded outputs — details below.

  • Articles 66
  • Projects 0
  • Books 3
  • Proceedings 65
  • Patents 0
  • Artistic 0
Scopus (SJR) Q1 13 Q2 36 Q3 18 Q4 6
WoS (JCR) Q1 13 Q2 24 Q3 26 Q4 10
TR Index 8 articles

Field+year+type normalized OpenAlex percentiles — not Clarivate ESI / SciVal.

Top 1% articles 4
Top 10% articles 17
Avg percentile 64.0%
Top 1% share 5.3%
Top 10% share 22.7%

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

Index filters

66 publications total

Scopus (SJR)
Q1 13 Q2 36 Q3 18 Q4 6
WoS (JCR)
Q1 13 Q2 24 Q3 26 Q4 10
TR Index
8 articles

Article list

  1. 2026 Novel Benzimidazole‐Urea Phenylalanine Hybrids as Dual‐Acting Antimicrobial and Anticancer Agents: In Silico and Biological Evaluation Chemical Biology & Drug Design DOI 10.1111/cbdd.70229 YÖKSİS SJR Q2 JCR Q3 OpenAlex 81.2%
  2. 2025 Novel Coumarin Derivatives: Synthesis, Characterization, Cytogenetics Effects on Allium cepa Root Cells, In Silico Molecular Docking, Structural and Electronic Analysis Studies ChemistrySelect DOI 10.1002/slct.202502679 YÖKSİS SJR Q3 JCR Q3 OpenAlex 80.2%
  3. 2025 Investigation of Anticancer Properties of Newly Synthesized Pyridazine-Based Inhibitors in Mouse and Human Breast Cancer Cell Line Biology (Basel) DOI 10.3390/biology14091193 YÖKSİS SJR Q1 JCR Q1 OpenAlex 65.3%
  4. 2025 Anticancer and Immunomodulatory Effects of a Thiazolyl Benzodiazepine Targeting HSP90 in ER+ Breast Cancer Pharmaceuticals DOI 10.3390/ph18111665 YÖKSİS SJR Q1 JCR Q1 OpenAlex 62.2%
  5. 2025 Design, Synthesis, and Evaluation of Benzimidazole‐Carbazole Hybrids Targeting Heat Shock Proteins‐Mediated Apoptosis in Breast and Colon Cancer Cells Drug Development Research DOI 10.1002/ddr.70092 YÖKSİS SJR Q2 JCR Q2 OpenAlex top 10% OpenAlex 92.9%
  6. 2024 Synthesis and biological studies of pyrimidine derivatives targeting metabolic enzymes Archiv der Pharmazie DOI 10.1002/ardp.202300634 YÖKSİS SJR Q2 JCR Q2 OpenAlex top 10% OpenAlex 98.5%
  7. 2024 Deciphering the Biophysical Properties of Ion Channel Gating Pores by Coumarin–Benzodiazepine Hybrid Derivatives: Selective AMPA Receptor Antagonists Molecular Neurobiology DOI 10.1007/s12035-023-03871-1 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 92.4%
  8. 2024 Synthesis of novel carbazole hydrazine-carbothioamide scaffold as potent antioxidant, anticancer and antimicrobial agents BMC Chemistry DOI 10.1186/s13065-024-01207-1 YÖKSİS SJR Q2 JCR Q2 OpenAlex top 1% OpenAlex 99.1%
  9. 2024 Hsp Inhibitor is Affective Against Adenocarcinomic Human Alveolar Basal Epithelial Cells Through Modulating ERK/MAPK Signaling Pathway Chemistry & Biodiversity DOI 10.1002/cbdv.202301422 YÖKSİS SJR Q3 JCR Q3 OpenAlex 60.9%
  10. 2023 Design, synthesis, molecular docking and biological evaluation of new carbazole derivatives as anticancer, and antioxidant agents BMC Chemistry DOI 10.1186/s13065-023-00961-y YÖKSİS SJR Q2 JCR Q2 OpenAlex top 10% OpenAlex 94.2%
  11. 2023 Synthesis of novel pyrazole-4-carboxylates by rearrangement reaction: Experimental and theoretical characterization Journal of Physics and Chemistry of Solids DOI 10.1016/j.jpcs.2023.111536 YÖKSİS SJR Q2 JCR Q2 OpenAlex 37.6%
  12. 2023 Synthesis, molecular docking, molecular dynamics and evaluation of Drug-Likeness properties of the fusedN-Formyl pyrazoline substituted new dehydroepiandrosterone derivatives Journal of Biomolecular Structure and Dynamics DOI 10.1080/07391102.2022.2034667 YÖKSİS SJR Q2 JCR Q2 OpenAlex 78.4%
  13. 2023 Molecular docking and antioxidant activity studies of imidodithiocarbonate derivatives containing pyrimidine Organic Communications DOI 10.25135/acg.oc.143.2212.2658 YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 35.4%
  14. 2023 Triad pyrazole-thiazole-coumarin heterocyclic core effectively inhibit HSP and drive cancer cells to apoptosis JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS DOI 10.1080/07391102.2023.2181643 YÖKSİS SJR Q2 JCR Q2 OpenAlex top 10% OpenAlex 90.6%
  15. 2022 Synthesis, dielectric properties, molecular docking and ADME studies of pyrrole-3-ones Journal of Biomolecular Structure and Dynamics (Informa UK Limited) DOI 10.1080/07391102.2021.1914174 YÖKSİS SJR Q2 JCR Q1 OpenAlex 86.5%
  16. 2022 Synthesis, DFT study, molecular docking and drug-likeness analysis of the heteroaryl substituted new pregnenolone derivatives Journal of Molecular Structure DOI 10.1016/j.molstruc.2022.132818 YÖKSİS SJR Q2 JCR Q2 OpenAlex 76.4%
  17. 2022 Utilization of pyrazole-perimidine hybrids bearing different substituents as corrosion inhibitors for 304 stainless steel in acidic media Journal of Molecular Structure DOI 10.1016/j.molstruc.2022.133025 YÖKSİS SJR Q2 JCR Q2 OpenAlex top 10% OpenAlex 94.2%
  18. 2022 Discovery of sulfadrug–pyrrole conjugates as carbonic anhydrase and acetylcholinesterase inhibitors Archiv der Pharmazie DOI 10.1002/ardp.202100242 YÖKSİS SJR Q2 JCR Q1 OpenAlex top 1% OpenAlex 99.6%
  19. 2022 Experimental and computational studies of 1,5-diphenyl-pyrazole-3-carboxamide compounds as potential Cannabinoid receptor type 1 Journal of molecular structure DOI 10.1016/j.molstruc.2022.133269 YÖKSİS SJR Q2 JCR Q2 OpenAlex 73.9%
  20. 2022 Pyrazolyl-Benzoxazinone Derivatives as Dual Hsp Inhibitors in Human Breast Cancer ChemistrySelect DOI 10.1002/slct.202200359 YÖKSİS SJR Q2 JCR Q3 OpenAlex 53.9%

Back to academicians